Correlation Between Homebiogas and Insuline Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Homebiogas and Insuline Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Homebiogas and Insuline Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Homebiogas and Insuline Medical, you can compare the effects of market volatilities on Homebiogas and Insuline Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Homebiogas with a short position of Insuline Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Homebiogas and Insuline Medical.

Diversification Opportunities for Homebiogas and Insuline Medical

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Homebiogas and Insuline is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Homebiogas and Insuline Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insuline Medical and Homebiogas is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Homebiogas are associated (or correlated) with Insuline Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insuline Medical has no effect on the direction of Homebiogas i.e., Homebiogas and Insuline Medical go up and down completely randomly.

Pair Corralation between Homebiogas and Insuline Medical

Assuming the 90 days trading horizon Homebiogas is expected to generate 0.97 times more return on investment than Insuline Medical. However, Homebiogas is 1.03 times less risky than Insuline Medical. It trades about -0.02 of its potential returns per unit of risk. Insuline Medical is currently generating about -0.11 per unit of risk. If you would invest  7,470  in Homebiogas on September 13, 2024 and sell it today you would lose (230.00) from holding Homebiogas or give up 3.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Homebiogas  vs.  Insuline Medical

 Performance 
       Timeline  
Homebiogas 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Homebiogas has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Insuline Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Insuline Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Homebiogas and Insuline Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Homebiogas and Insuline Medical

The main advantage of trading using opposite Homebiogas and Insuline Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Homebiogas position performs unexpectedly, Insuline Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insuline Medical will offset losses from the drop in Insuline Medical's long position.
The idea behind Homebiogas and Insuline Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies